论文信息 - Telavancin versus vancomycin for bacteraemic hospital-acquired pneumonia. - 字舞流文

Telavancin versus vancomycin for bacteraemic hospital-acquired pneumonia.

M. Niederman | A. Torres | E. Rubinstein | G. Corey | C. Luna | S. Barriere | M. Stryjewski | F. Genter | A. Lentnek | M. Magaña‐Aquino

[1] M. Niederman,et al. Telavancin versus Vancomycin for Hospital-Acquired Pneumonia due to Gram-positive Pathogens , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2] C. Kyriakopoulos,et al. PREDICTORS OF MORTALITY IN ADULT PATIENTS WITH VENTILATOR-ASSOCIATED PNEUMONIA: A META-ANALYSIS , 2010, Shock.

[3] M. Mammen,et al. Telavancin Disrupts the Functional Integrity of the Bacterial Membrane through Targeted Interaction with the Cell Wall Precursor Lipid II , 2009, Antimicrobial Agents and Chemotherapy.

[4] J. Rello,et al. Bacteremia in patients with ventilator-associated pneumonia is associated with increased mortality: A study comparing bacteremic vs. nonbacteremic ventilator-associated pneumonia* , 2007, Critical care medicine.